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Abstract. 
 
We have used time-lapse ﬂuorescence mi-
croscopy to study the properties of the Cdc25B and 
Cdc25C phosphatases that have both been implicated 
as initiators of mitosis in human cells. To differentiate 
between the functions of the two proteins, we have mi-
croinjected expression constructs encoding Cdc25B or 
Cdc25C or their GFP-chimeras into synchronized tissue 
culture cells. This assay allows us to express the proteins 
at deﬁned points in the cell cycle. We have followed the 
microinjected cells by time-lapse microscopy, in the 
presence or absence of DNA synthesis inhibitors, and 
assayed whether they enter mitosis prematurely or at 
the correct time. We ﬁnd that overexpressing Cdc25B 
alone rapidly causes S phase and G2 phase cells to en-
ter mitosis, whether or not DNA replication is com-
plete, whereas overexpressing Cdc25C does not cause 
premature mitosis. Overexpressing Cdc25C together 
with cyclin B1 does shorten the G2 phase and can over-
ride the unreplicated DNA checkpoint, but much less 
efﬁciently than overexpressing Cdc25B. These results 
suggest that Cdc25B and Cdc25C do not respond iden-
tically to the same cell cycle checkpoints. This differ-
ence may be related to the differential localization of 
the proteins; Cdc25C is nuclear throughout interphase, 
whereas Cdc25B is nuclear in the G1 phase and cyto-
plasmic in the S and G2 phases. We have found that the 
change in subcellular localization of Cdc25B is due to 
nuclear export and that this is dependent on cyclin B1. 
Our data suggest that although both Cdc25B and 
Cdc25C can promote mitosis, they are likely to have 
distinct roles in the controlling the initiation of mitosis.
Key words:  cell cycle • mitosis • green ﬂuorescent 
protein • nuclear export
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 Cdc25 phosphatase has a crucial and conserved
role in the initiation of mitosis in eukaryotic cells; it
activates the major mitotic protein kinase (com-
posed of cyclin B and its partner catalytic subunit cyclin-
dependent kinase 1 [CDK1])
 
1
 
 (Nurse, 1990; Dunphy,
1994). Cyclin B/CDK1 causes profound changes in the cell
architecture such as nuclear envelope breakdown and re-
organization of the microtubule and actin filament net-
works in part by directly phosphorylating a number of im-
portant structural components of the cell (for review see
Jackman and Pines, 1997; Nigg, 1993). In general, with the
exception of budding yeast (Amon et al., 1992; Sorger and
Murray, 1992), a pool of cyclin B–CDK1 complexes accu-
mulates through late S and G2 phase that is kept inactive
by phosphorylation on residues in the ATP binding site of
CDK1 (for review see Lew and Kornbluth, 1996). One of
these residues, tyrosine 15, is phosphorylated in all cells by
the Wee1/Mik1 kinase (Russell and Nurse, 1987a; Gould
and Nurse, 1989; Lundgren et al., 1991; Parker et al., 1992;
McGowan and Russell, 1993) and phosphorylation at this
site appears to interfere with phosphotransfer to a bound
substrate (Atherton Fessler et al., 1993). In animal cells,
and in fission yeast under certain conditions (Den Haese
et al., 1995), the adjacent residue, threonine 14, is phos-
phorylated by the membrane-bound Myt1 kinase (Korn-
bluth et al., 1994; Mueller et al., 1995; Booher et al., 1997;
Liu et al., 1997) that interferes with ATP binding (Booher
et al., 1997). The Cdc25 phosphatases are able to remove
the phosphate from both Y15 and T14 and thereby acti-
vate cyclin B/CDK1 (Dunphy and Kumagai, 1991; Gautier
et al., 1991; Kumagai and Dunphy, 1991; Millar et al.,
1991b; Strausfeld et al., 1991; Sebastian et al., 1993).
Initial experiments using fission yeast showed that cdc25
is a dosage-dependent regulator of mitosis (Russell and
Nurse, 1986) whose level is partially regulated by proteoly-
sis mediated by the pub1 gene product (Nefsky and Beach,
1996)
 
.
 
 Cells with a defective cdc25 gene product have a
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pronounced G2 delay before they enter mitosis, therefore,
they grow to a longer size than wild-type cells (Russell and
Nurse, 1986). Conversely, cells that overexpress cdc25 or
have a defect in the wee1 kinase that antagonizes cdc25,
enter mitosis prematurely and, therefore, divide at a
smaller size than normal cells
 
 
 
(Russell and Nurse, 1987b;
Enoch and Nurse, 1990). Thus, the balance between the
activities of cdc25 and wee1 determines when a cell enters
mitosis. This control mechanism is responsive to the state
of the DNA. Unreplicated or damaged DNA prevents
cells from entering mitosis by altering the balance between
the activities of cdc25 and wee1, such that fission yeast
cells with a mutant CDK1 (cdc2) gene that cannot be
phosphorylated by wee1/mik1 enter mitosis regardless of
the state of the DNA (Gould and Nurse, 1989; Enoch and
Nurse, 1990). Recently, the molecular mechanism linking
damaged DNA to the activation of CDK1 has been par-
tially elucidated. The Cds1 and Chk1 genes, which are ac-
tivated by unreplicated DNA and DNA damage (Boddy
et al., 1998; Blasina et al., 1999), phosphorylate a con-
served site on cdc25 to create a binding site for a 14-3-3
protein that prevents cdc25 from activating cyclin B/CDK1
(Furnari et al., 1997; Peng et al., 1997; Sanchez et al., 1997;
Lopez-Girona et al., 1999). In fission yeast, cds1 also phos-
phorylates the wee1 kinase and is required for the accu-
mulation of the mik1 kinase in response to unreplicated
DNA (Boddy et al., 1998).
The fundamental importance of the balance between
cdc25 and wee1 in preventing premature mitosis has also
been demonstrated in frog egg extracts (Smythe and New-
port, 1992) and in hamster (Heald et al., 1993) and human
tissue culture cells (Hagting et al., 1998). The complication
in human cells is that there are three different Cdc25
genes: Cdc25A, B, and C (Galaktionov and Beach, 1991;
Nagata et al., 1991). Of these, Cdc25A is present in G1
phase cells and appears to play a part in initiating DNA
replication (Hoffmann et al., 1994; Jinno et al., 1994).
However, both Cdc25B and Cdc25C, which are 45% iden-
tical at the amino acid level (85% identical in the catalytic
domains), are present in G2 phase cells; each appears to
be necessary for cells to enter mitosis, because microin-
jecting either anti-Cdc25B or anti-Cdc25C antibodies, or
transfecting cells with an inactive mutant of Cdc25B or
Cdc25C will block cells in the G2 phase (Millar et al.,
1991b; Gabrielli et al., 1996; Lammer et al., 1998). Never-
theless, there are indications that Cdc25B and Cdc25C
may not have redundant roles in the initiation of mitosis.
First, anti-Cdc25B immunoprecipitates have phosphatase
activity from S phase onwards that increases two- to four-
fold at mitosis, whereas anti-Cdc25C immunoprecipitates
are inactive until late G2/M phase (Gabrielli et al., 1996;
Nishijima et al., 1997; Lammer et al., 1998). In vitro,
Cdc25B is also more active than Cdc25C towards cyclin B/
CDK1 unless Cdc25C is activated by prior phosphoryla-
tion on its amino terminus. Second, Cdc25C is a nuclear
protein in human cells (Millar et al., 1991a; Girard et al.,
1992), whereas Cdc25B is reported to be cytoplasmic, but
to translocate to the nucleus at mitosis or when overex-
pressed (Gabrielli et al., 1996, 1997b). Third, in transient
transfection experiments overexpressing Cdc25C had no
effect on the cell cycle profile of cells as analyzed by flow
cytometry, whereas overexpressing Cdc25B caused a slow
 
increase in the population of G2/M cells and these cells
had abnormal mini-spindles (Gabrielli et al., 1996).
There are a number of problems associated with per-
forming cell cycle experiments in tissue culture cells. The
effects of introducing mutant proteins, or overexpressing
wild-type proteins, by transient transfection have to be in-
terpreted in a heterogeneous population of cells at fixed
points after transfection. Therefore, judging how a partic-
ular procedure has affected the cell cycle of any one cell is
mostly a matter of informed guesswork. Furthermore, it is
difficult to introduce a protein by transfection into cells at
a precise stage in the cycle, and, most importantly, progress
through the cell cycle, is often affected by the transfection
procedure itself (Winters et al., 1998). In an effort to over-
come these problems, we have begun to analyze the cell
cycle by time-lapse fluorescence microscopy (Hagting et al.,
1998). This allows us to follow individual cells through an
entire cell cycle. We have combined this with microinjec-
tion into synchronized cells to introduce cell cycle regula-
tors at defined points in the cell cycle. Furthermore, we in-
troduce regulators in the form of fusion proteins with a
modified form of green fluorescent protein (MmGFP)
(Zernicka-Goetz et al., 1996, 1997). This allows us to fol-
low the subcellular localization of specific proteins in real
time and gives us a dynamic view of their behavior when
the cell enters mitosis. Using this experimental regime,
we find that Cdc25B is a rate-limiting component of mito-
sis whose overexpression will overcome the unreplicated
DNA checkpoint. In contrast, Cdc25C does not accelerate
cells into mitosis unless it is coexpressed with cyclin B1,
and even this combination does not override the S phase
checkpoint. We confirm that there is a marked difference
in subcellular localization between Cdc25B and Cdc25C
and show that the cytoplasmic localization of Cdc25B is
regulated by nuclear export that is dependent on cyclin B1.
 
Materials and Methods
 
Cell Culture
 
HeLa cells were grown in DME supplemented with 5% newborn calf se-
rum, 5% FCS, and antibiotics. HeLa cells were synchronized using a thy-
midine-aphidicolin protocol (Pines and Hunter, 1989). Cells were cultured
on the microscope stage in a CO
 
2
 
-independent medium without phenol
red (GIBCO BRL). The medium was overlaid with mineral oil (Sigma
Chemical Co.) to prevent evaporation. Hydroxyurea was used at a final
concentration of 2.5 mM and was added immediately after release from
the aphidicolin block.
 
Plasmid Constructs and Protein Purification
 
The cyclin B1-MmGFP, cdc25C(S216G), and Wee1 constructs have been
previously described
 
 
 
(Hagting et al., 1998). Cyclin B1
 
R42A
 
-MmGFP was
the gift of Paul Clute (Wellcome/CRC Institute). Cdc25B3 and Cdc25C
were tagged at the amino terminus with MmGFP (Zernicka-Goetz et al.,
1996, 1997) by PCR using 
 
Taq
 
 polymerase and cloned into the pCMX vec-
tor (Umesono et al., 1991). The stop codon of GFP was mutated to a Hind
III site to link it with the first amino acid of Cdc25B or Cdc25C creating a
3–amino acid linker (Gly-Ile-Pro). Myc-tagged cdc25B2 (Lammer et al.,
1998) was cloned into the pCDNA3 vector for expression in HeLa cells.
All constructs were sequenced using an Applied Biosystems DNA se-
quencer. Cyclin B1–cdc2
 
K33R
 
 complexes were expressed in and purified
from baculovirus-infected cells as described (Hagting et al., 1998). Cy-
clin B1
 
F146A
 
 was expressed in 
 
Escherichia coli
 
 and purified as described
(Hagting et al., 1999). 
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Figure 1. Overexpressing cdc25B induces premature mitosis and not apoptosis. (A) HeLa cells in S phase were microinjected with
GFP-cdc25B3 cDNA at a concentration of 0.1mg/ml and cells were followed by time-lapse DIC microscopy. After 5 h cells were ana-
lyzed. Arrows indicate GFP-cdc25B–expressing cells. DIC (left), GFP fluorescence (center), and Hoechst 33342 staining (right). (B) GFP
fluorescence (left) and b-tubulin immunofluorescence (right). (C) GFP fluorescence (left) and MPM2 immunofluorescence (right). 
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Microinjection and PCC Detection
 
Constructs expressing cDNAs under the control of the cytomegalovirus
promoter were microinjected into cell nuclei using an Eppendorf semi-
automatic microinjection apparatus. To assay for condensed chromatin,
Hoechst 33342 was added to cells at a concentration of 1 
 
m
 
g/ml at the end
of the experiment. Injected cells were identified by green fluorescent pro-
tein (GFP) fluorescence and those that had rounded up with abnormally
condensed chromatin were scored. At least 50 cells were scored for each
injected construct and experiment. Apoptotic cells were assayed using the
apoptosis detection kit (R&D Systems, Inc.) and HeLa cells treated with
cycloheximide plus tumor necrosis factor 
 
a
 
 were used as positive controls.
 
Time-lapse Differential Interference Contrast (DIC) 
and Fluorescence Imaging
 
To visualize GFP-chimeras in living cells, cells were cultured on an in-
verted Leica DMIRB/E microscope using the 
 
D
 
TC3 system (Bioptechs) to
maintain cells at 37
 
8
 
C. Images were captured with a PentaMax CCD cam-
era (Princeton Instruments) fitted to the lateral photo port. GFP- and yel-
low fluorescent protein (YFP)–chimeras were detected with custom filter
sets JP1 and JP2 (Chroma Technology Corp.) and two Lambda 10-2 filter
wheels (Sutter Instrument) controlled by a PowerWave computer (Power-
Computing). One filter wheel was used to control the wavelength of the
excitation light. The other filter wheel controlled the wavelength of the
emission light and also the polarizer for DIC images. To distinguish be-
tween GFP and YFP we used the JP3 filter set as described (Hagting et al.,
1999). Images were collected and processed using IP Lab Spectrum soft-
ware (Scanalytics Inc.) and exported to Adobe Photoshop for printing.
 
Immunofluorescence and Confocal Imaging
 
For 
 
b
 
-tubulin and MPM2 staining, cells were fixed with 3% PFA/Triton
X-100 and stained as described (Pines, 1997) 3–4 h after microinjection.
Tubulin was detected using an anti–
 
b
 
-tubulin mAb (Nycomed Amer-
Figure 2. Frequency of PCC
induced by overexpressing
cdc25B in the S phase. Con-
structs encoding Cdc25B were
microinjected with or without
constructs encoding cyclin B1
into S phase HeLa cells, z1 h
after release from a thymi-
dine/aphidicolin block in the
absence (A) or presence (B)
of 2.5 mM hydroxyurea. One
of the constructs was ex-
pressed as a GFP-chimera to
detect injected cells. (Similar
results were obtained whether
Cdc25B or cyclin B1 was
linked to GFP.) Cells were fol-
lowed by DIC microscopy and
cells that rounded up were
counted at the indicated time
points after release. At the end
of the experiment, Hoechst
33342 was added to detect abnormally condensed chromatin and the cells expressing the GFP-chimera were counted and the frequency
of PCC was estimated. (A) Frequency of PCC in cells overexpressing cdc25B1/2 cyclin B1. (B) Frequency of PCC in cells overexpress-
ing cdc25B1/2 cyclin B1 in the presence of hydroxyurea. All constructs were injected at a concentration of 0.02 mg/ml. For cells in the
absence of hydroxyurea, the duration of S and G2 phases in the control cells are indicated. Data are the mean of three different experi-
ments.
Figure 3. Frequency of PCC
induced by overexpressing
cdc25C and cdc25C(S216G)
in the S phase. Constructs
encoding Cdc25C or a
Cdc25C(S216G) mutant were
microinjected with or without
cyclin B1 into S phase HeLa
cells in the absence (A) or
presence (B) of 2.5 mM hy-
droxyurea and followed by
DIC microscopy as described
in Fig. 2. (A) Frequency of
PCC in cells after release
from an aphidicolin block. (B)
Frequency of PCC in cells af-
ter release from an aphidi-
colin block in the presence of
hydroxyurea. Data are the
mean of three different exper-
iments. 
Karlsson et al. 
 
Cdc25B and Cdc25C Mitotic Initiators
 
577
 
sham) and mitotic epitopes were detected using the MPM2 mAb (Upstate
Biotechnology, Inc.). To detect myc-cdc25B2, pCDNA3/myc-cdc25B2
was microinjected (0.1 
 
m
 
g/
 
m
 
l) and cells were fixed with methanol/acetone
(1:1) 3 h after injection and stained with the mAb 9E10 (gift of Erich Nigg,
University of Geneva, Geneva). A Cy5 conjugated anti-mouse antibody
(Jackson ImmunoResearch Laboratories, Inc.) was used as the secondary
antibody. Cells were analyzed by confocal laser scanning microscopy using
a Bio-Rad 1024 confocal microscope set on 10% laser power and Kalman
averaging. Stacks of images were projected using Lasersharp software
(Bio-Rad Laboratories) and exported to Adobe Photoshop for processing
and printing.
 
Glutathione-S-transferase (GST) Pulldowns
 
Human cdc25B2, cdc25B3, cdc25C, and cyclin B1 were in vitro translated
from pBSK/cdc25B cDNA using the TNT-coupled reticulocyte system
(Promega Corp.). GST-cyclin B1, GST-Cdc25B2, GST-Cdc25B3, and
GST were expressed in BL21(DE3) cells using the pGEX-4T expression
vector and purified on GSH-Sepharose.
 
Results
 
Overexpression of cdc25B3 Causes Premature Mitosis 
in the Presence of Unreplicated DNA
 
To assay the role of the two types of mitotic Cdc25 phos-
phatases in the initiation of mitosis, expression constructs
encoding Cdc25B or Cdc25C, or the equivalent GFP-chi-
mera were introduced into synchronized HeLa cells by mi-
croinjection. The GFP-chimeras became visible about 3 h
after microinjection, and comparing the fluorescence be-
tween GFP-Cdc25B– and GFP-Cdc25C–expressing cells
showed that these proteins are expressed to similar levels
(data not shown). The behavior of the cells was followed
by DIC microscopy and the cell cycle phase was deter-
mined by flow cytometry and by incorporation of BrdU.
In these experiments, we primarily used the full-length
 
Cdc25B3 clone that is found in all cells (Baldin et al.,
1997b), but we detected only minor differences between
the behavior of this and the other two forms of Cdc25B
(data not shown). Using the GFP-chimeras we were able
to estimate the half-life of the proteins in cycloheximide–
chase experiments and found that there was little or no
difference in their turnover rate compared with the endog-
enous proteins (data not shown).
We found that overexpressing GFP-Cdc25B in early S
phase rapidly caused cells to round up and break down
their nuclear envelope (Figs. 1 A and 2 A). Staining the
cells with Hoechst 33342 showed that the chromatin had
condensed abnormally (Fig. 1 A) and anti–
 
b
 
-tubulin im-
munofluorescence staining revealed the presence of mini-
spindles as previously described (Gabrielli et al., 1996).
This suggested that the cells had entered mitosis prema-
turely rather than undergone apoptosis. To confirm this,
we stained cells with the MPM2 mAb that recognizes mi-
tosis-specific phospho-epitopes and for the apoptosis-
specific surface marker annexin V. Cells expressing
Cdc25B with abnormally condensed chromatin stained
very strongly with the MPM2 antibody (Fig. 1 C) but not
for annexin V (data not shown). Thus, we concluded that
Cdc25B caused cells to enter mitosis prematurely (prema-
ture chromosome condensation, PCC) rather than un-
dergo apoptosis. The GFP tag was not responsible for this
effect because the untagged Cdc25B cDNA induced pre-
mature mitosis with a similar frequency to GFP-Cdc25B
Figure 4. Overexpression of cdc25B together with cyclin B1 can
force G1 cells into premature mitosis. Cells in the G1 phase were
recognized by virtue of being attached after cytokinesis. Cells
were injected with constructs expressing GFP-cdc25B or GFP-
Cdc25C with or without constructs expressing a nondestructible
cyclin B1 (R42A) mutant. The frequency of PCC was determined
6 h after microinjection as described in Fig. 2. Data are represen-
tative of three different experiments.
Figure 5. Wee1 can rescue cells overexpressing cdc25B from
PCC. Cells were microinjected with expression constructs encod-
ing cdc25B with or without constructs expressing Wee1 at the in-
dicated concentrations (in mg/ml). 5 h later, Hoechst 33342 was
added and the frequency of PCC was determined as described in
Fig. 2. Data are the mean of four different experiments. 
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(not shown) and an inactive mutant of Cdc25B that lacked
the catalytic cysteine residue (C488S) could not induce
premature mitosis (not shown). Coinjecting a cyclin B1 ex-
pression vector with Cdc25B had only a minor effect on
the frequency of premature mitosis (Fig. 2 A).
In these experiments, cells were released from an aphid-
icolin block and, therefore, progressed through S phase in
the course of the experiment. We also wished to assay the
effect of overexpressing cdc25B in cells in which the un-
replicated DNA checkpoint was strongly activated. There-
fore, we microinjected cells with the Cdc25B expression
construct and released them from the aphidicolin block in
the presence of hydroxyurea. Under these conditions cells
progressed only very slowly through S phase as deter-
mined by flow cytometry (not shown). We found that
Cdc25B efficiently induced PCC in these cells, and, in this
case, coexpressing cyclin B1 greatly increased the fre-
quency of PCC (Fig. 2 B).
 
Overexpression of cdc25C Can Only Cause Premature 
Mitosis at the End of S Phase, and Only When 
Coexpressed with Cyclin B1
 
The effect of overexpressing Cdc25C in HeLa cells was
markedly different from that of overexpressing Cdc25B;
Cdc25C could not induce PCC when overexpressed alone.
Cdc25C was only able to cause a significant fraction of
cells to enter mitosis prematurely when cyclin B1 was also
overexpressed. Furthermore, overexpressing Cdc25C and
cyclin B1 could only cause PCC after cells had entered the
G2 phase (Fig. 3 A), not in the S phase cells. The unrepli-
cated DNA and G2 phase DNA damage checkpoints pre-
vent mitosis, at least in part, by acting on Cdc25C. Unrep-
licated DNA activates the Cds1 and Chk1 kinases; Chk1 is
also activated by DNA damage. Both kinases phosphory-
late Cdc25C on serine 216 to create a binding site for a 14-
3-3 protein that inactivates Cdc25C. Therefore, to test
whether Cdc25C was less potent than Cdc25B because it
was downregulated by Cds1 and/or Chk1, we used a
Cdc25C mutant that cannot be phosphorylated on serine
216 (S216G). Cdc25C
 
S216G
 
 was more efficient than wild-
type Cdc25C in causing PCC, but again this was only when
cyclin B1 was coexpressed (Fig. 3, A and B). Therefore,
downregulation by Cds1 and/or Chk1 is not sufficient to
explain the difference in potency between Cdc25B and
Cdc25C.
 
Overexpressing cdc25B, but Not Cdc25C, Together with 
Cyclin B1 Can Force G1 Cells into Mitosis
 
The potent ability of cdc25B to activate cyclin B1 and in-
duce premature mitosis raised the possibility that cdc25B
might be able to force cells into mitosis before they had
begun to replicate their DNA. At this stage in the cell cy-
cle, the proteolysis machinery that degrades the mitotic cy-
clins is still active (Amon et al., 1994; Brandeis and Hunt,
Figure 6. 
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Figure 6. The localization of Cdc25B and GFP-cdc25B in
HeLa cells depends on nuclear export. (A) Localization of
GFP-cdc25C after microinjection of expression constructs
into cells synchronized in G1, S, and G2 phases. GFP fluo-
rescence (left) and DIC image (right). (B) Localization of
GFP-cdc25B after microinjection of expression constructs
into cells synchronized in G1, S, and G2 phases. GFP fluo-
rescence (left) and DIC image (right). (C) Localization by
immunofluorescence of a myc-tagged cdc25B construct in
synchronized G1, S, and G2 HeLa cells. (D) Time-lapse
sequence of HeLa cells expressing GFP-cdc25B in the S
phase. Cells where GFP-cdc25B gradually becomes less
nuclear (open arrows). Cells where GFP-cdc25B is com-
pletely exported to the cytoplasm (closed arrows). Images
were captured at 10-min intervals. (E) Localization of
GFP-cdc25B in cells before (left) and 30 min after (right)
the addition of 20 nM LMB.
 
1996), therefore, we microinjected Cdc25B expression con-
structs with and without a cyclin B1 mutant (R42A) that
was resistant to degradation. We injected the constructs
into early G1 cells that had just flattened out after cyto-
kinesis. We found that overexpressing GFP-cdc25B alone
could not force cells into mitosis, but coexpressing the
nondegradable form of cyclin B1 caused PCC in 
 
z
 
50% of
the injected cells 6 h after injection. This would normally
correspond to the middle of G1 phase (Fig. 4). Further-
more, overexpressing Cdc25C, with or without cyclin B1,
or cyclin B1 alone did not force G1 phase cells into prema-
ture mitosis (Fig. 4 and data not shown).
 
Wee1 Rescues Cells from PCC in a
Dose-dependent Manner
 
The balance between the inhibitory kinases of cdc2, Wee1,
and Myt1, and Cdc25C phosphatase is crucial to the timing
of mitosis (Smythe and Newport, 1992; Heald et al., 1993;
Hagting et al., 1998). Therefore, we coinjected varying
amounts of expression constructs for Cdc25B and for
Wee1 kinase to see whether Wee1 could counteract the
ability of Cdc25B to cause PCC. We found that Cdc25B in-
duced PCC in a dose-dependent manner and that Wee1
could rescue Cdc25B-expressing cells, again in a dose-
dependent fashion (Fig. 5). 
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Cdc25B Localization Changes Because of
Nuclear Export
 
We considered the possibility that the differences in the
abilities of Cdc25B and Cdc25C to force cells into mitosis
might be related to the differences in their localization.
Human Cdc25C is usually found to be a nuclear protein
(Millar et al., 1991a; Girard et al., 1992) and our Cdc25C
chimera is also nuclear throughout interphase (Fig. 6 A).
Cdc25B has been previously described as a cytoplasmic
protein that colocalizes with centrosomes and becomes
nuclear at the end of the G2 phase (Gabrielli et al., 1996,
1997b). To verify that the GFP-Cdc25B chimeras localized
correctly, we compared their localization with a myc
epitope-tagged Cdc25B, reasoning that the nine amino ac-
ids of the myc epitope would be unlikely to perturb the lo-
calization of Cdc25B. HeLa cells were synchronized in the
G1, S, and G2 phases and the myc-tagged Cdc25B protein
localization was determined by immunofluorescence after
microinjection of a myc-cdc25B expression construct (Fig.
6 C). Cells expressing the GFP-cdc25B chimera were fol-
lowed by time-lapse fluorescence microscopy (Fig. 6, B
and D) at different stages of the cell cycle.
We found that Cdc25B was nuclear in the G1 phase and
gradually moved from the nucleus to the cytoplasm as cells
progressed through S phase. Unfortunately, we were un-
able to visualize the endogenous Cdc25B by immunofluo-
rescence, but we were able to confirm that Cdc25B was
substantially nuclear in G1/S phase cells and accumulated
in the cytoplasm by immunoblotting nuclear and cytoplas-
mic fractions through the cell cycle (not shown). These re-
sults suggested that Cdc25B might be exported from the
nuclei of S and G2 phase cells. Most nuclear export path-
ways reported so far depended on exportin 1/Crm1, which
can be inactivated by leptomycin B (LMB) (Nishi et al.,
1994; Fornerod et al., 1997; Kudo et al., 1997; Wolff et al.,
1997). Therefore, we added LMB to cells expressing GFP-
cdc25B in G2 phase and found that LMB caused GFP-
cdc25B to accumulate in the nucleus within 30 min (Fig. 6
E), indicating that the localization of Cdc25B is regulated
by nuclear export.
 
The Cytoplasmic Localization of cdc25B Is Dependent 
on Cyclin B1
 
Although the cytoplasmic localization of Cdc25B in S and
G2 phases depended on Crm1-mediated nuclear export,
Cdc25B was nuclear in the G1 phase. The cytoplasmic lo-
calization of Cdc25B correlated with the point in the cell
cycle when cyclin B1 started to accumulate and cyclin B1
has been shown to be exported from nuclei in an LMB-
sensitive manner (Hagting et al., 1998; Toyoshima et al.,
1998; Yang et al., 1998). Taken together these observa-
tions suggested that cyclin B1 might be involved in mediat-
ing the cytoplasmic localization of Cdc25B. To test this hy-
pothesis, we expressed GFP-cdc25B in early G1 phase or
early S phase cells (i.e., cells that lack any endogenous cy-
clin B1), and then microinjected purified cyclin B1 or cy-
clin B1/CDK1
 
K33R
 
 protein into the nucleus. GFP-cdc25B
was immediately and rapidly exported from G1 (not
shown) or S phase nuclei (Fig. 7 A) after injecting cyclin
B1/CDK1
 
K33R 
 
and reentered the nuclei when LMB was
added to inhibit export (Fig. 7 A). This effect was ob-
 
served using cyclin B1 in a complex with a kinase-dead
mutant of CDK1, which strongly suggested that cyclin B1
itself and not CDK1 kinase activity was required for
cdc25B export. In support of this, we found that GFP-
cdc25B still accumulated in the cytoplasm of G2 phase
cells in the presence of the CDK1 inhibitor, roscovitin
(data not shown). Furthermore, a cyclin B1 mutant with a
defective nuclear export signal, cyclin B1
 
F146A
 
, did not
cause nuclear Cdc25B to be exported when microinjected
into G1 (Fig. 7 B) or S phase nuclei (not shown). These
observations suggested that Cdc25B export could be
due to a direct interaction between cyclin B1/CDK1 and
Cdc25B. In support of this, we were able to detect an in
vitro interaction between Cdc25B and cyclin B1 that ap-
peared to be slightly stronger than an association between
cyclin B1 and Cdc25C (Fig. 7 C).
 
Discussion
 
In this paper, we have used time-lapse microscopy to show
that Cdc25B and Cdc25C differ markedly in their abilities
to induce mitosis. Our assay allowed us to determine the
effects on progress through the cell cycle of overexpress-
ing specific proteins at defined points in the cell cycle. In
this way, we were able to avoid the problems of trying to
analyze the effects of overexpressing proteins by transfec-
tion in a heterogeneous population of cells that must be
fixed for immunofluorescence at arbitrary time points. We
have shown that simply overexpressing Cdc25B is suffi-
cient to induce premature mitosis when there is cyclin B1
in the cell regardless of the replication state of the DNA.
In contrast, Cdc25C will only cause premature mitosis when
it is overexpressed with cyclin B1 and this does not over-
ride the negative signal generated by unreplicated DNA.
We have also shown that the subcellular localization of
Cdc25B changes through the cell cycle and is regulated by
nuclear export, most likely by binding to cyclin B1.
Our demonstration that overexpressing Cdc25C alone
cannot overcome the unreplicated DNA checkpoint, but
that Cdc25B can, suggests that Cdc25C and Cdc25B are
regulated in different ways. Cdc25C appears to require a
further activation step that can be partially supplied by in-
creasing the level of cyclin B (Heald et al., 1993). Indeed,
an extra copy of cyclin B (NIME) can partially suppress a
mutation in cdc25 (NIMT) in 
 
Aspergillus nidulans
 
 
 
(O’Con-
nell et al., 1992). This activation step is most likely to be
phosphorylation of the amino terminus of Cdc25C, which
activates its phosphatase activity 
 
z
 
10-fold in vitro, and cy-
clin B/Cdk1 is able to phosphorylate and activate Cdc25C
(Izumi et al., 1992; Kumagai and Dunphy, 1992; Hoffmann
et al., 1993; Izumi and Maller, 1995; Gabrielli et al., 1997a).
More recently, members of the polo-like family of kinases
have been shown to phosphorylate and activate Cdc25C
(Kumagai and Dunphy, 1996), but it is unclear whether
they initiate Cdc25C activation at the end of G2 phase.
In this regard, we were unable to activate prematurely
Cdc25C by coexpressing human plk1 (data not shown), al-
though this may be because plk1 itself needs to be acti-
vated by phosphorylation (Qian et al., 1998). Our data
show that Cdc25C activation is either prevented, or rap-
idly reversed, in the presence of unreplicated DNA. The
inhibition of Cdc25C may be partially effected through 
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ylates Cdc25B in vitro and this correlates with a fourfold
increase in Cdc25B activity (Gabrielli et al., 1996, 1997a;
Lammer et al., 1998). One explanation could be that cyclin
B/CDK1 activates Cdc25B and vice versa in a positive
feedback loop, and that this is more potent than the posi-
tive feedback loop between Cdc25C and cyclin B1/CDK1
because Cdc25B and cyclin B1/CDK1 are both cytoplas-
mic. If Cdc25B and cyclin B do activate one another, then
the resulting positive feedback loop must be carefully reg-
ulated because overexpressing Cdc25B is sufficient to cause
 
phosphorylation on S216 and the consequent binding of a
14-3-3 protein (Boddy et al., 1998; Rhind and Russell,
1998). However, this cannot provide a full explanation, be-
cause we found that although an S216G mutant form of
Cdc25C is able to promote premature mitosis more rap-
idly than the wild-type Cdc25C, it is unable to overcome
the DNA replication checkpoint.
In contrast, it appears that Cdc25B either does not need
an activation step or that the activator is present whenever
cyclin B1 is present. Furthermore, cyclin B/Cdk1 phosphor-
Figure 7. GFP-cdc25B is exported from the nucleus after injec-
tion of Cyclin B1/CDK1K33R and can bind to cyclin B1 in vitro.
(A) HeLa cells were synchronized in the S phase and microin-
jected with a GFP-cdc25B expression construct immediately after
release from an aphidicolin block. 3 h later, z40 pg of cyclin B1/
CDK1K33R expressed in, and purified from, baculovirus was mi-
croinjected into the nucleus and GFP images were taken at the in-
dicated time points. 9 min after the injection of cyclinB1/
CDK1K33R, 20 nM LMB was added to the cells and a final image
captured 10 min later. (B) HeLa cells were synchronized in the S
phase and microinjected with a YFP-cdc25B expression construct
3 h after mitosis. 3 h later, z40 pg of a nuclear export–defective
cyclin B1 (F146A)-GFP was microinjected into the nucleus and
YFP images were taken at the indicated time points using a filter set that distinguishes between GFP and YFP (Hagting et al., 1999). (C)
Physical interaction between cdc25B and cyclin B1. (Left) 35S-Labeled, in vitro translated cdc25B2 and cdc25B3 and Cdc25C were incubated
with GST alone or GST-cyclin B1. (Right) 35S-Labeled in vitro translated cyclin B1 was incubated with GST alone, or GST-Cdc25B2, or GST-
Cdc25B3. The complexes were bound to glutathione-Sepharose, washed extensively, separated by SDS-PAGE, and exposed to film. 
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premature mitosis, regardless of whether the DNA has
been replicated. One way in which Cdc25B might be regu-
lated is by protein turnover. Cdc25B is an unstable pro-
tein, with a half-life of 
 
,
 
30 min in hamster and HeLa cells
(Nishijima et al., 1997), which can be targeted for degra-
dation in vitro by cyclin A-CDK2 (Baldin et al., 1997a).
Thus, Cdc25B may be primarily regulated by ubiquitin-
mediated proteolysis in an analogous fashion to cdc25 in
fission yeast (Nefsky and Beach, 1996).
Remarkably, we found that when Cdc25B and cyclin B1
were coexpressed in G1 phase cells the cells attempted to
enter mitosis, showing that cell division and DNA replica-
tion can be uncoupled in human cells. This may also be rel-
evant to how the cell causes two sequential M phases in
meiosis and it will be interesting to determine whether
Cdc25B is required for gametogenesis.
Despite the differences in their regulation, both Cdc25B
and Cdc25C are antagonized by Wee1. Wee1 and Cdc25C
are both nuclear proteins and, therefore, their relative ac-
tivities will determine whether the nucleus will activate or
inhibit cyclin B/CDK1 when it is imported into the nu-
cleus. However, Cdc25B is primarily a cytoplasmic protein
in the G2 phase and so might act on the predominantly cy-
toplasmic pool of cyclin B/CDK1. Therefore, Wee1 may
only counteract the effects of Cdc25B when active cyclin
B1/Cdk1 shuttles into the nucleus (Hagting et al., 1998).
Human Cdc25B was originally described as being a cy-
toplasmic protein that translocated to the nucleus at mito-
sis in concert with cyclin B (Gabrielli et al., 1996, 1997b).
However, these studies were performed by immunofluo-
rescence in which the exact cell cycle stage of an individual
cell was often difficult to judge, except by the appearance
of condensed chromosomes. We have shown here that
Cdc25B is nuclear in G1 cells, but gradually accumulates
in the cytoplasm as cells progress through the S and G2
phases. Furthermore, Cdc25B will accumulate in the nu-
cleus when S or G2 phase cells are treated with LMB, a
specific inhibitor of crm1/exportin1–mediated nuclear ex-
port (Nishi et al., 1994; Fornerod et al., 1997; Wolff et al.,
1997). This suggests that the localization of Cdc25B, like
that of cyclin B1 (Hagting et al., 1998; Toyoshima et al.,
1998; Yang et al., 1998), is primarily determined by nu-
clear export. However, Cdc25B does not have a recogniz-
able nuclear export signal (Bogerd et al., 1996) and is nu-
clear in the G1 phase. When we microinjected wild-type
cyclin B1 into the nuclei of G1 cells, we observed that
cdc25B was immediately exported, but not when we mi-
croinjected an export-defective cyclin B1. Furthermore,
we found that cyclin B1 binds to Cdc25B in an in vitro
binding assay. These results suggest that the cytoplasmic
localization of cdc25B depends upon cyclin B1, and that
the two proteins are likely to be exported together from
the nucleus. This is reminiscent of recent results showing
that fission yeast cdc25C is exported from the nucleus af-
ter DNA damage by binding to the rad24 14-3-3 protein
(Lopez-Girona et al., 1999). In both cases, the Cdc25 pro-
tein does not have a nuclear export signal itself, but is ex-
ported by virtue of its association with another export-
capable protein.
In conclusion, we have demonstrated marked differ-
ences in the abilities of Cdc25B and Cdc25C to promote
mitosis and in their cell cycle behavior. Our results suggest
that controlling the level of Cdc25B is crucial to prevent
premature mitosis, whereas Cdc25C can be regulated at a
subsequent step, most likely by phosphorylation. The ac-
tivity of Wee1 in the nucleus is very important in counter-
acting the effects of both the nuclear Cdc25C and the
primarily cytoplasmic Cdc25B, emphasizing the dynamic
nature of the interactions between cell cycle components
that shuttle between the nucleus and the cytoplasm.
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